From: Clinical study of a new skin antiseptic olanexidine gluconate in gastrointestinal cancer surgery
Organisms | OLG group (n = 6) | Control group (n = 6) |
---|---|---|
Enterococcus faecalis | 2 (33.3%) | 0 (0%) |
Enterococcus avium | 1 (16.7%) | 0 (0%) |
Enterobacter aerogenes | 1 (16.7%) | 0 (0%) |
Enterobacter cloacae | 1 (16.7%) | 0 (0%) |
Pseudomonas aeruginosa | 1 (16.7%) | 0 (0%) |
Klebsiella pneumoniae | 1 (16.7%) | 0 (0%) |
Escherichia coli | 1 (16.7%) | 1 (16.7%) |
Streptococcus constellatus | 0 (0%) | 2 (33.3%) |
MSSA | 0 (0%) | 1 (16.7%) |
Citrobacter freundii | 0 (0%) | 1 (16.7%) |
Corynebacterium sp | 0 (0%) | 1 (16.7%) |
γ-streptococcus | 0 (0%) | 1 (16.7%) |